食药监局发布“致癌物”权威清单,每个人都要看一看!

2016-12-19 编辑:王真 健康时报

虽说现在医学发达但某些病还是没能攻克比如说令人谈之色变的癌!症!一条条触目惊心的“健康提醒”在微信、微博上被频频转发面对这些真伪难辨的消息大家难免会更心慌不过小编接下来准备公布最权威“致癌物列表”!它是武汉市食品药品监督管理局发布的这些致癌物的汇总来自世界卫生组织国际癌症研究中心(IARC)所以很权威这个机构还特别贴心在列表中还分了等级有的等级致癌物是真的致癌有的等级只是怀疑可能会致癌有的则是不太

虽说现在医学发达,但某些病还是没能攻克,比如说令人谈之色变的,癌!症!


一条条触目惊心的“健康提醒”,在微信、微博上被频频转发

面对这些真伪难辨的消息,大家难免会更心慌,不过小编接下来准备公布最权威“致癌物列表”!它是武汉市食品药品监督管理局发布的,这些致癌物的汇总来自世界卫生组织国际癌症研究中心(IARC),所以很权威。这个机构还特别贴心,在列表中还分了等级,有的等级致癌物是真的致癌,有的等级只是怀疑可能会致癌,有的则是不太可能致癌。


具体等级


1类致癌物:指导致人类癌症的证据很明确的,简单说就是,真的致癌!


2类致癌物:指导致人类癌症的证据不明确的,简单说就是,不一定致癌!其中,2类致癌物也分为2A类和2B类,致癌可能性2A>2B。


3类致癌物:指导致动物和人致癌的证据都不明确,其实这一类导致癌症的可能性非常非常小。


4类致癌物:基本上没有,就是几乎不可能致癌。


咱们今天的名单就是前三类的,先从最严重的说起,赶紧对照一下。是不是自己接触过这些东西,有则改之,无则加勉!


1类致癌物


1类致癌物代表


酒精和酒精饮料:主要是导致肝癌。

香烟:富含各种致癌物,导致多器官癌症。


中式咸鱼:主要是有亚硝胺类化合物,导致消化道癌症,比如典型的鼻咽癌。


太阳辐射、紫外线、美容院的日光浴设备:主要导致皮肤癌。

苯并芘:常见于烤肉中,无烟烤肉相对好一些,它也是汽车尾气中的成分之一。


黄曲霉毒素B1:常见于霉变的花生和粮食,土榨花生油中很多见。


槟榔:主要导致口腔癌。


:室内空气污染,主要是在氡本底值高的地区。


砷、镉、苯、二噁英、煤焦油:主要来自工农业污染和职业病。


另外,室内烧煤、橡胶工业、木屑等也被列入1类致癌物,特别说明:不过,别以为只要是1类致癌物就都厉害!癌症的分级只是看致癌证据是否可靠,是否充分,而不是看它导致癌症的能力强不强。


2类致癌物


2类致癌物代表

丙烯酰胺:常见于薯条、薯片、油条等高温处理的食物,不过主要来源是炒菜(爆炒)。


黄曲霉毒素M1:常见于牛奶,主要是牛的饲料被霉菌污染,南方地区多见。


:主要来自工农业污染,过去含铅汽油是城市铅污染的主要来源。


咖啡


红肉


4-甲基咪唑:焦糖色的副产物,常见于酱油、可乐等,不过含量极低,致癌概率可以忽略不计。


汽油:可能是因为其中含有的少量芳香族化合物。 


特别说明:这类致癌物,在人类致癌上还没有明确证实,大家注意点就行。


3类致癌物


3类致癌物代表


汞、皮革加工、苏丹红、三聚氰胺、二氧化硫、双氧水、次氯酸、印刷油墨、氨苄西林、聚乙烯、聚丙烯、聚氯乙烯、玻璃纤维。煤粉、铁锈、咖啡因、胆固醇、静态磁场、茶、维生素K。 


特别说明:这类物品导致动物和人致癌的证据都不明确,其实这一类导致癌症的可能性非常非常小。


看完这些真是涨知识!


小编的建议是


有的致癌物请尽量避免,如烟酒,能戒掉就戒掉吧!


有的致癌物要权衡利弊,都知道X光致癌,但是生病了也得照啊!


有的致癌物需要控制,比如红肉、烧烤啥的,吃点没事,只要不是长期大量吃就行。


不过,多运动、均衡饮食、注意睡眠、不熬夜、少加班,用健康的方式生活才是最重要的!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1949158, encodeId=2d6b1949158c1, content=<a href='/topic/show?id=4cb8101143c9' target=_blank style='color:#2F92EE;'>#食药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101143, encryptionId=4cb8101143c9, topicName=食药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sat Jul 08 08:45:00 CST 2017, time=2017-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076197, encodeId=64ed20e619756, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Feb 14 03:45:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165347, encodeId=6cff16534e61, content=知识很重要,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Sat Dec 24 16:28:02 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301547, encodeId=28fe130154e6f, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370874, encodeId=ef7813e087407, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448821, encodeId=f9e4144882139, content=<a href='/topic/show?id=8dde8651197' target=_blank style='color:#2F92EE;'>#致癌物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86511, encryptionId=8dde8651197, topicName=致癌物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3005440223, createdName=qjddjq, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164117, encodeId=60a716411e78, content=分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27c31981931, createdName=1e185577m68(暂无匿称), createdTime=Mon Dec 19 18:22:20 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164111, encodeId=90c816411116, content=我看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Mon Dec 19 16:44:08 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164094, encodeId=59a316409420, content=有些是避免不开的, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Mon Dec 19 14:19:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164055, encodeId=6a3916405557, content=竟是些谣言, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161128/IMG583C2801690655672.jpg, createdBy=8d5d1986050, createdName=为了宝宝, createdTime=Mon Dec 19 12:34:29 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1949158, encodeId=2d6b1949158c1, content=<a href='/topic/show?id=4cb8101143c9' target=_blank style='color:#2F92EE;'>#食药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101143, encryptionId=4cb8101143c9, topicName=食药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sat Jul 08 08:45:00 CST 2017, time=2017-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076197, encodeId=64ed20e619756, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Feb 14 03:45:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165347, encodeId=6cff16534e61, content=知识很重要,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Sat Dec 24 16:28:02 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301547, encodeId=28fe130154e6f, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370874, encodeId=ef7813e087407, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448821, encodeId=f9e4144882139, content=<a href='/topic/show?id=8dde8651197' target=_blank style='color:#2F92EE;'>#致癌物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86511, encryptionId=8dde8651197, topicName=致癌物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3005440223, createdName=qjddjq, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164117, encodeId=60a716411e78, content=分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27c31981931, createdName=1e185577m68(暂无匿称), createdTime=Mon Dec 19 18:22:20 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164111, encodeId=90c816411116, content=我看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Mon Dec 19 16:44:08 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164094, encodeId=59a316409420, content=有些是避免不开的, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Mon Dec 19 14:19:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164055, encodeId=6a3916405557, content=竟是些谣言, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161128/IMG583C2801690655672.jpg, createdBy=8d5d1986050, createdName=为了宝宝, createdTime=Mon Dec 19 12:34:29 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1949158, encodeId=2d6b1949158c1, content=<a href='/topic/show?id=4cb8101143c9' target=_blank style='color:#2F92EE;'>#食药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101143, encryptionId=4cb8101143c9, topicName=食药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sat Jul 08 08:45:00 CST 2017, time=2017-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076197, encodeId=64ed20e619756, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Feb 14 03:45:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165347, encodeId=6cff16534e61, content=知识很重要,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Sat Dec 24 16:28:02 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301547, encodeId=28fe130154e6f, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370874, encodeId=ef7813e087407, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448821, encodeId=f9e4144882139, content=<a href='/topic/show?id=8dde8651197' target=_blank style='color:#2F92EE;'>#致癌物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86511, encryptionId=8dde8651197, topicName=致癌物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3005440223, createdName=qjddjq, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164117, encodeId=60a716411e78, content=分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27c31981931, createdName=1e185577m68(暂无匿称), createdTime=Mon Dec 19 18:22:20 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164111, encodeId=90c816411116, content=我看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Mon Dec 19 16:44:08 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164094, encodeId=59a316409420, content=有些是避免不开的, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Mon Dec 19 14:19:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164055, encodeId=6a3916405557, content=竟是些谣言, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161128/IMG583C2801690655672.jpg, createdBy=8d5d1986050, createdName=为了宝宝, createdTime=Mon Dec 19 12:34:29 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
    2016-12-24 cqykthl

    知识很重要,学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1949158, encodeId=2d6b1949158c1, content=<a href='/topic/show?id=4cb8101143c9' target=_blank style='color:#2F92EE;'>#食药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101143, encryptionId=4cb8101143c9, topicName=食药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sat Jul 08 08:45:00 CST 2017, time=2017-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076197, encodeId=64ed20e619756, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Feb 14 03:45:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165347, encodeId=6cff16534e61, content=知识很重要,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Sat Dec 24 16:28:02 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301547, encodeId=28fe130154e6f, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370874, encodeId=ef7813e087407, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448821, encodeId=f9e4144882139, content=<a href='/topic/show?id=8dde8651197' target=_blank style='color:#2F92EE;'>#致癌物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86511, encryptionId=8dde8651197, topicName=致癌物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3005440223, createdName=qjddjq, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164117, encodeId=60a716411e78, content=分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27c31981931, createdName=1e185577m68(暂无匿称), createdTime=Mon Dec 19 18:22:20 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164111, encodeId=90c816411116, content=我看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Mon Dec 19 16:44:08 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164094, encodeId=59a316409420, content=有些是避免不开的, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Mon Dec 19 14:19:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164055, encodeId=6a3916405557, content=竟是些谣言, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161128/IMG583C2801690655672.jpg, createdBy=8d5d1986050, createdName=为了宝宝, createdTime=Mon Dec 19 12:34:29 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
    2016-12-21 xuyu
  5. [GetPortalCommentsPageByObjectIdResponse(id=1949158, encodeId=2d6b1949158c1, content=<a href='/topic/show?id=4cb8101143c9' target=_blank style='color:#2F92EE;'>#食药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101143, encryptionId=4cb8101143c9, topicName=食药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sat Jul 08 08:45:00 CST 2017, time=2017-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076197, encodeId=64ed20e619756, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Feb 14 03:45:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165347, encodeId=6cff16534e61, content=知识很重要,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Sat Dec 24 16:28:02 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301547, encodeId=28fe130154e6f, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370874, encodeId=ef7813e087407, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448821, encodeId=f9e4144882139, content=<a href='/topic/show?id=8dde8651197' target=_blank style='color:#2F92EE;'>#致癌物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86511, encryptionId=8dde8651197, topicName=致癌物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3005440223, createdName=qjddjq, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164117, encodeId=60a716411e78, content=分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27c31981931, createdName=1e185577m68(暂无匿称), createdTime=Mon Dec 19 18:22:20 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164111, encodeId=90c816411116, content=我看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Mon Dec 19 16:44:08 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164094, encodeId=59a316409420, content=有些是避免不开的, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Mon Dec 19 14:19:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164055, encodeId=6a3916405557, content=竟是些谣言, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161128/IMG583C2801690655672.jpg, createdBy=8d5d1986050, createdName=为了宝宝, createdTime=Mon Dec 19 12:34:29 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
    2016-12-21 jambiya
  6. [GetPortalCommentsPageByObjectIdResponse(id=1949158, encodeId=2d6b1949158c1, content=<a href='/topic/show?id=4cb8101143c9' target=_blank style='color:#2F92EE;'>#食药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101143, encryptionId=4cb8101143c9, topicName=食药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sat Jul 08 08:45:00 CST 2017, time=2017-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076197, encodeId=64ed20e619756, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Feb 14 03:45:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165347, encodeId=6cff16534e61, content=知识很重要,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Sat Dec 24 16:28:02 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301547, encodeId=28fe130154e6f, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370874, encodeId=ef7813e087407, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448821, encodeId=f9e4144882139, content=<a href='/topic/show?id=8dde8651197' target=_blank style='color:#2F92EE;'>#致癌物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86511, encryptionId=8dde8651197, topicName=致癌物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3005440223, createdName=qjddjq, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164117, encodeId=60a716411e78, content=分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27c31981931, createdName=1e185577m68(暂无匿称), createdTime=Mon Dec 19 18:22:20 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164111, encodeId=90c816411116, content=我看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Mon Dec 19 16:44:08 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164094, encodeId=59a316409420, content=有些是避免不开的, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Mon Dec 19 14:19:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164055, encodeId=6a3916405557, content=竟是些谣言, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161128/IMG583C2801690655672.jpg, createdBy=8d5d1986050, createdName=为了宝宝, createdTime=Mon Dec 19 12:34:29 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
    2016-12-21 qjddjq
  7. [GetPortalCommentsPageByObjectIdResponse(id=1949158, encodeId=2d6b1949158c1, content=<a href='/topic/show?id=4cb8101143c9' target=_blank style='color:#2F92EE;'>#食药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101143, encryptionId=4cb8101143c9, topicName=食药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sat Jul 08 08:45:00 CST 2017, time=2017-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076197, encodeId=64ed20e619756, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Feb 14 03:45:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165347, encodeId=6cff16534e61, content=知识很重要,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Sat Dec 24 16:28:02 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301547, encodeId=28fe130154e6f, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370874, encodeId=ef7813e087407, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448821, encodeId=f9e4144882139, content=<a href='/topic/show?id=8dde8651197' target=_blank style='color:#2F92EE;'>#致癌物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86511, encryptionId=8dde8651197, topicName=致癌物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3005440223, createdName=qjddjq, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164117, encodeId=60a716411e78, content=分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27c31981931, createdName=1e185577m68(暂无匿称), createdTime=Mon Dec 19 18:22:20 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164111, encodeId=90c816411116, content=我看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Mon Dec 19 16:44:08 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164094, encodeId=59a316409420, content=有些是避免不开的, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Mon Dec 19 14:19:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164055, encodeId=6a3916405557, content=竟是些谣言, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161128/IMG583C2801690655672.jpg, createdBy=8d5d1986050, createdName=为了宝宝, createdTime=Mon Dec 19 12:34:29 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
    2016-12-19 1e185577m68(暂无匿称)

    分享

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1949158, encodeId=2d6b1949158c1, content=<a href='/topic/show?id=4cb8101143c9' target=_blank style='color:#2F92EE;'>#食药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101143, encryptionId=4cb8101143c9, topicName=食药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sat Jul 08 08:45:00 CST 2017, time=2017-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076197, encodeId=64ed20e619756, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Feb 14 03:45:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165347, encodeId=6cff16534e61, content=知识很重要,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Sat Dec 24 16:28:02 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301547, encodeId=28fe130154e6f, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370874, encodeId=ef7813e087407, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448821, encodeId=f9e4144882139, content=<a href='/topic/show?id=8dde8651197' target=_blank style='color:#2F92EE;'>#致癌物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86511, encryptionId=8dde8651197, topicName=致癌物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3005440223, createdName=qjddjq, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164117, encodeId=60a716411e78, content=分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27c31981931, createdName=1e185577m68(暂无匿称), createdTime=Mon Dec 19 18:22:20 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164111, encodeId=90c816411116, content=我看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Mon Dec 19 16:44:08 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164094, encodeId=59a316409420, content=有些是避免不开的, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Mon Dec 19 14:19:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164055, encodeId=6a3916405557, content=竟是些谣言, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161128/IMG583C2801690655672.jpg, createdBy=8d5d1986050, createdName=为了宝宝, createdTime=Mon Dec 19 12:34:29 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
    2016-12-19 xiaotaiyang1

    我看过了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1949158, encodeId=2d6b1949158c1, content=<a href='/topic/show?id=4cb8101143c9' target=_blank style='color:#2F92EE;'>#食药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101143, encryptionId=4cb8101143c9, topicName=食药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sat Jul 08 08:45:00 CST 2017, time=2017-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076197, encodeId=64ed20e619756, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Feb 14 03:45:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165347, encodeId=6cff16534e61, content=知识很重要,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Sat Dec 24 16:28:02 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301547, encodeId=28fe130154e6f, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370874, encodeId=ef7813e087407, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448821, encodeId=f9e4144882139, content=<a href='/topic/show?id=8dde8651197' target=_blank style='color:#2F92EE;'>#致癌物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86511, encryptionId=8dde8651197, topicName=致癌物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3005440223, createdName=qjddjq, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164117, encodeId=60a716411e78, content=分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27c31981931, createdName=1e185577m68(暂无匿称), createdTime=Mon Dec 19 18:22:20 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164111, encodeId=90c816411116, content=我看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Mon Dec 19 16:44:08 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164094, encodeId=59a316409420, content=有些是避免不开的, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Mon Dec 19 14:19:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164055, encodeId=6a3916405557, content=竟是些谣言, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161128/IMG583C2801690655672.jpg, createdBy=8d5d1986050, createdName=为了宝宝, createdTime=Mon Dec 19 12:34:29 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
    2016-12-19 永圣

    有些是避免不开的

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1949158, encodeId=2d6b1949158c1, content=<a href='/topic/show?id=4cb8101143c9' target=_blank style='color:#2F92EE;'>#食药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101143, encryptionId=4cb8101143c9, topicName=食药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sat Jul 08 08:45:00 CST 2017, time=2017-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076197, encodeId=64ed20e619756, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Feb 14 03:45:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165347, encodeId=6cff16534e61, content=知识很重要,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Sat Dec 24 16:28:02 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301547, encodeId=28fe130154e6f, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370874, encodeId=ef7813e087407, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448821, encodeId=f9e4144882139, content=<a href='/topic/show?id=8dde8651197' target=_blank style='color:#2F92EE;'>#致癌物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86511, encryptionId=8dde8651197, topicName=致癌物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3005440223, createdName=qjddjq, createdTime=Wed Dec 21 01:45:00 CST 2016, time=2016-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164117, encodeId=60a716411e78, content=分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27c31981931, createdName=1e185577m68(暂无匿称), createdTime=Mon Dec 19 18:22:20 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164111, encodeId=90c816411116, content=我看过了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Mon Dec 19 16:44:08 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164094, encodeId=59a316409420, content=有些是避免不开的, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Mon Dec 19 14:19:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164055, encodeId=6a3916405557, content=竟是些谣言, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161128/IMG583C2801690655672.jpg, createdBy=8d5d1986050, createdName=为了宝宝, createdTime=Mon Dec 19 12:34:29 CST 2016, time=2016-12-19, status=1, ipAttribution=)]
    2016-12-19 为了宝宝

    竟是些谣言

    0

相关资讯

新增7个!共248个!美发布第14版“致癌物”报告(附详单)

导语:日前,美国卫生及公共服务部发布了最新版致癌物报告,纳入了7种新的物质。此次更新后,共有248种物质被列为致癌物。一起来看看具体都是哪些物质吧。日前,美国卫生及公共服务部(Department of Health and Human Services)发布了第14版致癌物报告(14th Report on Carcinogens),纳入了7种新的物质。此次更新后,共有248种物质被列为致癌物。

世卫组织正式公布:加工肉类为1类致癌物

MedSci得到最新消息,世界卫生组织下属的国际癌症研究机构(IARC)刚刚正式公布:加工肉类为1类致癌物,红肉为2类致癌物。此前传言得到证实。原文如下:Overall, the Working Group classified consumption of processed meat as “carcinogenic to humans” (Group 1) on the basis of s

食用油中检出致癌物

  国家质检总局近日通报28类产品质量国家监督抽查结果。涉及食品方面,有两种食用油苯并(a)芘超标、一种炒货花生米黄曲霉毒素B1超标,这两种物质均为致癌物。   通报显示,食用植物油产品质量合格率为93.9%,其中吉林省吉林市天下粮仓工贸有限公司“东北纯”笨榨熟豆油(5L/桶)、黑龙江八旗粮油有限公司“八旗”大豆油(1.2L/桶)的苯并(a)芘实测值是标准值的2倍~3倍。炒货食品合格率为97.8

安全吃烧烤,降低致癌物

  人们都知道,烧烤烹制过程中从木炭和食物中释放出来的烟雾里含有致癌物质。然而,的确有不少人喜欢吃烧烤。其实,在烧烤过程中只要采取一些额外的正确步骤,就能将致癌物质对人体的损害作用减至最低。   美国哈佛大学医学院丹娜-法伯癌症研究所的专家认为:高温烧烤会将红肉、猪肉、家禽肉和鱼肉中蛋白质转化为杂环胺,而杂环胺与多种癌症(包括乳腺癌、结肠癌、胃癌和前列腺癌)有关。当肉中的脂肪和肉汁滴下并生成烟雾

2016年全新致癌物发布

日前,世界卫生组织(WHO)部属的世界癌症研讨机构发布了最新陈述:警告饮用65℃以上的热饮,也许添加罹患食道癌的危险。记者在采访中发现,烫食烫饮的确是食道癌的高危因素。世卫:十分热的饮料被列入2A致癌物这项最新的评价陈述发表在15日出版的《柳叶刀肿瘤学》杂志上。陈述指出,在我国、土耳其及南美洲国家的研讨发现,这些区域的大家一般习气饮用65℃或70℃以上的水、咖啡或茶,罹患食管癌的危险也随之进步。陈

世卫将65℃以上饮料列为很可能致癌物

世界卫生组织(WHO)下属的国际癌症研究机构(IARC)发布了最新报告,正式下调咖啡及南美草本茶的致癌风险评级,表示现阶段没有足够证据证明两者与癌症有关;但同时警告饮用65℃以上的热饮,可能增加罹患食道癌的风险。 这项最新的评估报告发表在15日出版的《柳叶刀肿瘤学》杂志上。报告指出,在中国、土耳其及南美洲国家的研究发现,这些地区的人们通常习惯饮用65℃或70℃以上的水、咖啡或茶,罹患食管癌的